Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
5.75
+0.32 (5.89%)
At close: Oct 29, 2025, 4:00 PM EDT
5.56
-0.19 (-3.30%)
Pre-market: Oct 30, 2025, 4:01 AM EDT
Aethlon Medical Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
9
Market Cap
4.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | 574.25K | 280.08K | 95.21% |
| Mar 31, 2022 | 294.17K | -364.94K | -55.37% |
| Mar 31, 2021 | 659.10K | 8.92K | 1.37% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
AEMD News
- 22 days ago - Aethlon Medical's Hemopurifier® shows Changes in Extracellular Vesicles, Extracellular MicroRNAs, and T Cell Numbers in Australian Oncology Clinical Trial - PRNewsWire
- 7 weeks ago - Aethlon Medical Announces Pricing of $4.5 Million Public Offering - PRNewsWire
- 2 months ago - Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC) - PRNewsWire
- 2 months ago - Aethlon Medical, Inc. (AEMD) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update - PRNewsWire
- 3 months ago - Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025 - PRNewsWire
- 3 months ago - Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort - PRNewsWire
- 4 months ago - Aethlon Medical, Inc. (AEMD) Q4 2025 Earnings Call Transcript - Seeking Alpha